CVS and Rite Aid have filed an antitrust lawsuit against Wyeth and Teva in New Jersey federal court. The pharmacies allege that the two drug manufacturers conspired to keep generics of Effexor XR off the market and agreed to prolong Teva’s generic exclusivity rights. The complaint also accuses Wyeth of obtaining fraudulent patents and engaging in sham litigation.
Featured News
Apple Hires American Airlines Veteran to Lead Government Affairs
Aug 12, 2026 by
CPI
PayPal Defeats Antitrust Challenge to Merchant Payment Rules
Aug 12, 2026 by
CPI
New York City Opens Probe Into Polymarket’s Marketing Practices
Aug 12, 2026 by
CPI
German Soccer’s Ownership Model Gets Antitrust Path Forward
Aug 12, 2026 by
CPI
Microsoft Seeks Dismissal of Gamers’ Antitrust Claims Over Valve Deal
Aug 12, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes